SCHEMBL31156725

SCHEMBL31156725

CC1(C)OB(c2ccccc2-c2ccc(-c3nc(-c4ccccc4)cc(-c4ccccc4)n3)cc2)OC1(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 10/20 0.45
▸ KMT2A Q03164 10/20 0.45
▸ MAPT P10636 8/20 0.45
▸ ALDH1A1 P00352 7/20 0.45
▸ HPGD P15428 7/20 0.45
▸ LPL P06858 2/20 0.45
▸ LIPG Q9Y5X9 2/20 0.45
▸ NTSR1 P30989 1/20 0.45
▸ KDM4E B2RXH2 5/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ LMNA P02545 2/20 0.40
▸ GLA P06280 1/20 0.40
▸ MAOB P27338 5/20 0.40
▸ MAOA P21397 3/20 0.40
▸ ADORA2A P29274 1/20 0.40
▸ ADORA1 P30542 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ ATM Q13315 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22649975 0.93 MEN1 (0.43) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22113569 0.92 LPL (0.50) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL31074774 0.91 LIPG (0.46) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL29276571 0.91 MEN1 (0.44) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25864406 0.90 LPL (0.45) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL27403487 0.87 LPL (0.45) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL27369208 0.87 LIPG (0.47) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL38659883 0.86 LPL (0.50) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL23105621 0.86 LPL (0.52) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL28567849 0.85 LIPG (0.48) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240298531-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME LG CHEM, LTD. (KR) 2024-09-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240298531-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING SAME L1CAM, CRY2, NAP1L1 MEN1 967/4885KMT2A 468/4885MAPT 2587/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback